September 28, 2017 / 12:53 PM / in 23 days

BRIEF-Rockwell files Calcitriol post-approval manufacturing submission with FDA

Sept 28 (Reuters) - Rockwell Medical Inc:

* Rockwell files Calcitriol post-approval manufacturing submission with FDA

* Rockwell Medical-co expects Calcitriol to be commercially available in U.S. about 30 days after CMC submission, provided FDA has no further requests Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below